BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 29291370)

  • 21. STC1 promotes cell apoptosis via NF-κB phospho-P65 Ser536 in cervical cancer cells.
    Pan X; Jiang B; Liu J; Ding J; Li Y; Sun R; Peng L; Qin C; Fang S; Li G
    Oncotarget; 2017 Jul; 8(28):46249-46261. PubMed ID: 28545028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
    J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.
    Baritaki S; Militello L; Malaponte G; Spandidos DA; Salcedo M; Bonavida B
    Int J Oncol; 2011 Jun; 38(6):1683-94. PubMed ID: 21455568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.
    Secchiero P; Gonelli A; Carnevale E; Milani D; Pandolfi A; Zella D; Zauli G
    Circulation; 2003 May; 107(17):2250-6. PubMed ID: 12668516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of NF-kappaB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin.
    Jani TS; DeVecchio J; Mazumdar T; Agyeman A; Houghton JA
    J Biol Chem; 2010 Jun; 285(25):19162-72. PubMed ID: 20424169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRMT5, a novel TRAIL receptor-binding protein, inhibits TRAIL-induced apoptosis via nuclear factor-kappaB activation.
    Tanaka H; Hoshikawa Y; Oh-hara T; Koike S; Naito M; Noda T; Arai H; Tsuruo T; Fujita N
    Mol Cancer Res; 2009 Apr; 7(4):557-69. PubMed ID: 19372584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS; Chang I; Kim JY; Choi KH; Lee MS
    Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
    Mitsiades CS; Mitsiades N; Poulaki V; Schlossman R; Akiyama M; Chauhan D; Hideshima T; Treon SP; Munshi NC; Richardson PG; Anderson KC
    Oncogene; 2002 Aug; 21(37):5673-83. PubMed ID: 12173037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.
    Dai Y; Liu M; Tang W; Li Y; Lian J; Lawrence TS; Xu L
    BMC Cancer; 2009 Nov; 9():392. PubMed ID: 19895686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of Biglycan is Associated with Resistance to Rapamycin in Human WERI-Rb-1 Retinoblastoma Cells by Inducing the Activation of the Phosphatidylinositol 3-Kinases (PI3K)/Akt/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
    Fang D; Lai Z; Wang Y
    Med Sci Monit; 2019 Sep; 25():6639-6648. PubMed ID: 31483776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
    Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
    J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Arsenic trioxide enhances TRAIL inducing human lung cancer cell line A549 cells apoptosis by down-regulate the expression of NF-kappaB].
    Wang JY; Zhao XQ; Wang CM; Mo BW; Jiang M; Chen F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):834-8. PubMed ID: 23387208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astaxanthin inhibits NF-κB and Wnt/β-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer.
    Kavitha K; Kowshik J; Kishore TK; Baba AB; Nagini S
    Biochim Biophys Acta; 2013 Oct; 1830(10):4433-44. PubMed ID: 23726989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells.
    Shlyakhtina Y; Pavet V; Gronemeyer H
    Cell Death Dis; 2017 Aug; 8(8):e3025. PubMed ID: 29048428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231.
    Rwigemera A; Mamelona J; Martin LJ
    Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.
    Ravi R; Bedi GC; Engstrom LW; Zeng Q; Mookerjee B; Gélinas C; Fuchs EJ; Bedi A
    Nat Cell Biol; 2001 Apr; 3(4):409-16. PubMed ID: 11283615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells.
    Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway.
    Nguyen DM; Chen GA; Reddy R; Tsai W; Schrump WD; Cole G; Schrump DS
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):365-75. PubMed ID: 14762343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells.
    Deng LL; Shao YX; Lv HF; Deng HB; Lv FZ
    Neoplasma; 2012; 59(1):18-29. PubMed ID: 22017589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.